Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells-Reference-Cited by-同舟云学术

Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells

Published:2023-09 Issue: Volume:30 Page:56-71
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Magnani Chiara F.^ORCID,Myburgh Renier,Brunn Silvan,Chambovey Morgane,Ponzo Marianna,Volta Laura,Manfredi Francesco,Pellegrino Christian,Pascolo Steve,Miskey Csaba,Sandoval-Villegas Nicolás,Ivics Zoltán,Shizuru Judith A.,Neri Dario,Manz Markus G.

Funder

Swiss National Science Foundation

Swiss Cancer League

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference65 articles.

1. Epidemiology and biology of relapse after stem cell transplantation;Horowitz;Bone Marrow Transpl.,2018

2. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell;Bonnet;Nat. Med.,1997

3. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice;Lapidot;Nature,1994

4. Biology and relevance of human acute myeloid leukemia stem cells;Thomas;Blood,2017

5. Immune Biology of Acute Myeloid Leukemia: Implications for Immunotherapy;Khaldoyanidi;J. Clin. Oncol.,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modified heated CGMD simulations for discovering stable docked conformations of BiTE antibody against CD3 and CD117/c-kit;Molecular Simulation;2024-07-24

2. Efficient Combinatorial Adaptor-Mediated Targeting of Acute Myeloid Leukemia with CAR T-Cells;2024-07-15

3. Aberrant stem cell and developmental programs in pediatric leukemia;Frontiers in Cell and Developmental Biology;2024-03-27

4. mRNA‐based chimeric antigen receptor T cell therapy: Basic principles, recent advances and future directions;Interdisciplinary Medicine;2023-12-29

5. Challenges facing minimal residual disease testing for acute myeloid leukemia and promising strategies to overcome them;Expert Review of Hematology;2023-11-21